World’s

Most Adopted

Healthcare AI

20M+
Lives impacted to date
90+
Countries via 3100+ sites
1B+
Training Datasets
astrazeneca_logo.svg
aarthi-scans.svg
caritas-logo.svg
astrazeneca_logo.svg
aarthi-scans.svg
caritas-logo.svg
astrazeneca_logo.svg
aarthi-scans.svg
caritas-logo.svg
astrazeneca_logo.svg
aarthi-scans.svg
caritas-logo.svg
astrazeneca_logo.svg
aarthi-scans.svg
caritas-logo.svg
astrazeneca_logo.svg
aarthi-scans.svg
caritas-logo.svg
Transforming Healthcare Pathways with AI
Mask group (3).svg
Frame 1000002851 (1).svg
Advancing Public Health 
Access for Tuberculosis, Paediatric TB & Beyond
Our WHO-evaluated solutions support clinicians in making quick and accurate diagnosis and treatment decisions, promoting global access to Tuberculosis, Silicosis, and Paediatric Tuberculosis care, and facilitating real-time disease surveillance.
See How
LC.webp
Frame 1000002851 (1).svg
Accelerating 
Early Detection and Treatment in Lung Cancer
The end-to-end Lung Cancer care continuum detects lung nodules early, measures for disease progression and manages cases to support clinicians and improve outcomes for patients. It also helps advance developments for lung health in the pharmaceutical industry.
See How
Stroke.webp
Frame 1000002851 (1).svg
Enhancing Timely Intervention in Stroke Care
Our WHO-evaluated solutions support clinicians in making quick and accurate diagnosis and treatment decisions, promoting global access to Tuberculosis, Silicosis, and Paediatric Tuberculosis care, and facilitating real-time disease surveillance.
See How
The Global Impact of AI:  Real Stories, 
Real Lives Transformed 
From Aims to Achievements: Fulfilling Clinical & Business Goals 
Explore Our Latest Developments 
The utility of artificial intelligence in identifying radiological evidence of lung cancer and pulmonary tuberculosis in a high-burden tuberculosis setting
Read Study
Z Z Nxumalo, E M Irusen, B W Allwood, M Tadepalli, J Bassi, C F N Koegelenberg
See more evidence

Chest X-ray interpretation tools like qXR can help prioritise potential lung cancer patients, ensuring they are fast-tracked for CT scans. We work with Qure to evaluate AI's role across Greater Manchester and how it can help meet the NHS's recommended guidelines for lung cancer diagnosis.

Dr. Rhidian Bramley

Consultant Radiologist, Clinical Lead for Diagnostics, Digital, and Innovation at Greater Manchester Cancer Alliance

Dr Rhidian.webp

abcabcabcabcabcabcabc

abc

abc

abc

def

def

def

def

ghighighighighighi

ghi

ghighi

ghi

jkljkljkljkljkljkljkljkljkljkljkljkljkljkljkljkljkljkl

jkl

jkl

jkl

qTrack
Our AI-powered reporting and seamless collaboration platform offers an end-to-end solution for screening programs and case management. It enables enhanced care coordination and monitors program health developments through customized dashboards. 
Frame 11704.svg